Skip to content
First Access is open No payment required
gut theory.

Education

The GX-5™ approach: five roles, one deliberate formula

GX-5™ is our framework for building The Daily Buffer around complementary everyday gut functions—without hiding the active amounts.

Gut products are often arranged around a fashionable ingredient or the largest number that fits on a label. We started with a different question: what defined daily roles could sit together in one transparent formula?

The framework

GX-5™ organises The Daily Buffer into five roles: digestive enzymes, prebiotic fibre, named probiotic strains, gut-lining nutrients and selected plant compounds. It is a formulation framework, not a biological claim that the gut has only five pathways.

01

Food breakdown

Five digestive enzymes selected to support the breakdown of carbohydrates, protein, fats, fibre and lactose. Enzymes act on specific substrates; they do not make every food universally symptom-free.

02

Prebiotic fibre

Six grams across acacia fibre and partially hydrolysed guar gum (PHGG), selected for microbial fermentation and regularity support. Different fibres are not interchangeable, and tolerance remains individual.

03

Named probiotic strains

Ten billion CFU across S. boulardii CNCM I-745, B. coagulans BC30 and B. subtilis DE111. We name strains because probiotic evidence is often strain- and dose-specific.

04

Gut-lining nutrients

L-glutamine, N-acetyl glucosamine and zinc are included as nutrients associated with the cells and mucosal structures of the gastrointestinal lining. This is nutritional support language—not treatment of “leaky gut” or disease.

05

Selected plant compounds

Black seed oil powder and quercetin sit within the wider formula as disclosed plant-derived ingredients. We do not use their presence to borrow disease claims from isolated or preclinical studies.

Three design principles

1. Disclose the dose.

Proprietary blends make it difficult to compare a label with published research. Every active amount in The Daily Buffer is disclosed.

2. Match specificity.

A probiotic species name is not the same as a strain. A fibre category is not the same as a defined ingredient. Our science communication should remain as specific as the evidence.

3. Build for real routines.

The formula is one tablespoon, once daily. It is designed to complement a balanced diet and healthy lifestyle—not to replace them or erase the effect of an extreme dietary pattern.

An evidence map, not a borrowed clinical trial

Human research exists for several individual ingredients or strains in GX-5™, including PHGG, acacia fibre, S. boulardii CNCM I-745, BC30 and DE111. Populations, doses and outcomes vary. The finished Daily Buffer formula has not been evaluated as a complete product in a published randomised clinical trial, so we do not present ingredient studies as if they were a trial of the finished formula.

Transparency includes the limit.

Evidence-informed formulation is not the same thing as product-level clinical proof. We will keep that distinction visible as the research program develops.

What we do not claim

  • That The Daily Buffer diagnoses, treats, cures or prevents disease.
  • That it offsets every consequence of a consistently poor diet.
  • That one microbiome profile defines health.
  • That every person will feel the same outcome on the same timeline.
  • That evidence for one strain or ingredient automatically transfers to another.

Selected evidence

  1. PHGG, stool form and the gut microbiota.
  2. Acacia fibre in a randomised placebo-controlled IBS-C trial.
  3. S. boulardii CNCM I-745 human randomised study.
  4. BC30 and gastrointestinal function in healthy adults.
  5. Pilot randomised trial of B. subtilis DE111.
  6. ISAPP probiotic consensus statement.